BB....don't know of any now in clinical trials. However, you don't hear a great deal about the numerous Alzheimer's drugs until they fail or underproforn in clinical trials. I would say that we are among the leaders or are the leader in the home stretch....unless the FDA accepts Biogen's flimsy data on Aducanumab.